SLUPP 332

Scientific Benefits

• Targeted Lipolysis — Directly activates hormone-sensitive lipase (HSL) in adipocytes, triggering the breakdown of stored triglycerides into free fatty acids.
• Visceral Fat Reduction — Shows preferential activity against metabolically harmful visceral adipose tissue, reducing abdominal fat accumulation.
• Enhanced Fat Oxidation — Increases the rate at which mobilized free fatty acids are transported into mitochondria and oxidized for ATP production.
• Metabolic Rate Elevation — Upregulates basal metabolic rate through beta-adrenergic receptor sensitization and thermogenic pathway activation.
• Muscle Preservation — Targets fat stores preferentially, supporting lean body mass retention.
• Appetite Modulation — May exert mild appetite-suppressing effects via central signaling, supporting overall caloric deficit goals.
• Improved Insulin Sensitivity — Reduction in visceral fat mass is associated with downstream improvements in insulin receptor sensitivity and glucose homeostasis.
• Synergistic Potential — Combines effectively with GLP-1 agonists, GH peptides, and AOD-9604 in comprehensive body recomposition protocols.